Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection - 2-Year Outcomes

N Engl J Med. 2023 Nov 9;389(19):1822-1824. doi: 10.1056/NEJMc2308286.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cytomegalovirus Infections* / congenital
  • Cytomegalovirus Infections* / immunology
  • Cytomegalovirus Infections* / therapy
  • Female
  • Humans
  • Immunoglobulins / therapeutic use
  • Immunoglobulins, Intravenous / therapeutic use
  • Pregnancy
  • Pregnancy Complications, Infectious* / etiology
  • Pregnancy Complications, Infectious* / immunology
  • Pregnancy Complications, Infectious* / therapy
  • Treatment Outcome

Substances

  • Immunoglobulins
  • Immunoglobulins, Intravenous

Grants and funding